The cytotoxic and growth inhibitory effects of palladium(ii) complexes on MDA-MB-435 cells

Genetics and Molecular Biology

Volumn 35, Issue 1, 2012, Pages 159-163

  Campanella, Nathália Cristina ^a   da Silva Demartini, Mariana ^b   Torres, Claudia ^b   De Almeida, Eduardo Tonon ^b   Gouvêa, Cibele Marli Cação Paiva ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adenocarcinoma cells; Antitumor; Breast cancer; Chemotherapy; Coordination complexes

Indexed keywords

CISPLATIN; ESTROGEN RECEPTOR ALPHA; PALLADIUM COMPLEX; SULFORHODAMINE B;

ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL DAMAGE; CELL SHRINKAGE; CELL SIZE; CELL STRAIN; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INCUBATION TIME; MDA MB 435 CELL; NUCLEAR CONDENSATION; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

EID: 84858258221     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572012005000016     Document Type: Article

References (19)

1. Anderson BO (2010) The breast health global initiative (BHGI): Why it matters to all of us. Oncology 24:1-10.
2. Barbosa CM, Oliveira CR, Nascimento FD, Smith MC, Fausto DM, Soufen MA, Sena E, Araújo RC, Tersariol IL, Bincoletto C, et al. (2006) Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells. Eur J Pharmacol 542:37-47.
3. Brough R, Frankum JR, Costa-Cabral S, Lord CJ and Ashworth A (2011) Searching for synthetic lethality in cancer. Curr Opin Genet Dev 21:31-41.
4. Caires AC (2007) Recent advances involving palladium (II) complexes for cancer. Anticancer Agents Med Chem 7:484-491.
5. Caires ACF, Almeida ET, Mauro AE, Hemerly JP and Valentini SR (1999) Síntese e atividade citotóxica de alguns azidociclopaladados estabilizados com ligantes bifosfínicos. Quim Nova 22:329-333.
6. Ekwall B, Silano V, Paganuzzi-Stammati A and Zucco F (1990) Toxicity tests with mammalian cell cultures. In: Bourdeau P, Somers E, Richardson GM and Hickman JR (eds) Short- Term Toxicity Tests for Non-Genotoxic Effects. John Wiley & Sons, Inc., New York, pp 75-97.
7. Gao EJ, Wang L, Zhu MC, Liu L and Zhang WZ (2010) Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of the complexes [M(dmphen)(CO3)].H2O[M= Pt(II), Pd(II)]. Eur J Med Chem 45:311-316.
8. Gao E, Liu L, Zhu M, Huang Y, Guan F, Gao X, Zhang M, Wang L, Zhang W and Sun Y (2011) Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[ d]thiazol-2-amine as the primary ligand. Inorg Chem 50:4732-4741.
9. Giacinti L, Claudio PP, Lopez M and Giordano A (2006) Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11:1-8.
10. Jemal A, Center MM, DeSantis C and Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893-1907.
11. Kontek R, Matawska-Wasowska K, Kalinowska-Lis U, Kontek B and Ochocki J (2011) Evaluation of cytotoxicity of new trans-palladium(II) complex in human cells in vitro. Acta Pol Pharm 68:127-136.
12. Le Tourneau C, Diéras V, Tresca P, Cacheux W and Paoletti X (2010) Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents. Target Oncol 5:65-72.
13. Oldenhuis CN, Oosting SF, Gietema JA and de Vries EG (2008) Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer 44:946-953.
14. Pedro M, Lourenço CF, Cidade H, Kijjoa A, Pinto M and Nascimento MS (2006) Effects of natural prenylated flavones in the phenotypical ER (+) MCF-7 and ER (-) MDA-MB-231 human breast cancer cells. Toxicol Lett 164:24-36.
15. Rocha MC, Santana AM, Ananias SR, Almeida ET, Mauro AE, Placeres MCP and Carlos IZ (2007) Cytotoxicity and immune response induced by organopalladium(II) compounds in mice bearing Ehrlich ascites tumour. J Braz Chem Soc 18:1473-1480.
16. Rybak LP, Mukherjea D, Jajoo S and Ramkumar V (2009) Cisplatin ototoxicity and protection: Clinical and experimental studies. Tohoku J Exp Med 219:177-186.
17. Sahab ZJ, Man YG, Byers SW and Sang QX (2011) Putative biomarkers and targets of estrogen receptor negative human breast cancer. Int J Mol Sci 12:4504-4521
18. Sumantran VN (2011) Cellular chemosensitivity assays: An overview. In: Cree IA (ed) Cancer Cell Culture: Methods and Protocols (Methods in Molecular Biology 731 Springer Protocols). 2nd edition. Humana Press, New Jersey, pp 219-236.
19. Vichai V and Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1:1112-1116.